跳至主要内容
临床试验/NCT00579995
NCT00579995终止不适用

A Prospective, Randomized Trial Comparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate for the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing Cardiac Catheterization

University of Nebraska1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2005年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
41
试验地点
1
主要终点
Compare the Effectiveness of Two Medications for Prevention of Contrast-induced Nephropathy

研究概览

简要总结

The purpose of this study is to compare the efficacy of oral N-acetylcysteine and intravenous sodium bicarbonate for the prevention of Contrast-Induced Nephropathy (CIN) after cardiac catheterization.

详细描述

It is thought that N-acetylcysteine may reduce the ability of generated oxygen free radicals to damage cells by scavenging them. N-acetylcysteine may also increase the biologic effects of nitric oxide by combining with nitric oxide to form S-nitrosothiol, a more stable form and potent vasodilator. It also increases the expression of nitric oxide synthesis and may improve blood flow. Oxidants activate a signal-transduction cascade and molecular response that may initiate the cell-death pathway. These pathways seem to be sensitive to the redox state of the cell and are inhibited by N-acetylcysteine, which promotes pathways that lead to repair and survival whenever cells are under oxidant stress.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 19 years of age
  • Baseline serum creatinine or
  • Calculated creatinine
  • Stable Renal Function
  • Left Ventricular ejection fraction
  • Non-pregnant, non-lactating females (all women of childbearing potential must have a negative serum pregnancy test. No contraception will be required
  • Able to sign informed consent

排除标准

  • Acute renal failure
  • History of Kidney transplant
  • Currently receiving N-acetylcysteine
  • _ Contraindication of hypersensitivity to N-acetylcysteine or sodium bicarbonate
  • Left ventricular ejection fraction
  • Pregnant, lactating females
  • Allergy to contrast dye

研究组 & 干预措施

N-Acetylcysteine

Active Comparator

Oral N-Acetylcysteine 600 mg

干预措施: Oral N-Acetylcysteine (Drug)

Sodium Bicarbonate

Active Comparator

Sodium bicarbonate 3 milliliter per kilogram per hour (3 mL/kg/hr) infused at 1 mL/kg/hr for 6 hours post-procedure

干预措施: Sodium Bicarbonate (Drug)

结局指标

主要结局

Compare the Effectiveness of Two Medications for Prevention of Contrast-induced Nephropathy

时间窗: 2 years

Compare oral N-Acetylcysteine and intravenous sodium bicarbonate for the prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Prospective, Randomized TrialComparing Oral... | 临床试验